Campbell SB - Search Results

1

A single-centre experience of post-renal transplant lymphoproliferative disorder.

Herzig KA, Juffs HG, Norris D, Brown AM, Gill D, Hawley CM, Cobcroft R, Petrie JB, Marlton P, Thomson D, Campbell SB, Nicol DL, Johnson DW. Herzig KA, et al. Among authors: campbell sb. Transpl Int. 2003 Jul;16(7):529-36. doi: 10.1007/s00147-003-0596-0. Epub 2003 May 7. Transpl Int. 2003. PMID: 12734646

2

Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.

Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, Petrie JJ. Hawley CM, et al. Among authors: campbell sb. Am J Kidney Dis. 1995 Oct;26(4):658-61. doi: 10.1016/0272-6386(95)90605-3. Am J Kidney Dis. 1995. PMID: 7573023

3

Mononeuritis multiplex complicating Henoch-Schonlein purpura.

Campbell SB, Hawley CM, Staples C. Campbell SB, et al. Aust N Z J Med. 1994 Oct;24(5):580. doi: 10.1111/j.1445-5994.1994.tb01767.x. Aust N Z J Med. 1994. PMID: 7848168 No abstract available.

4

Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features.

Campbell S, Clarke P, Hawley C, Wigan M, Kerlin P, Butler J, Wall D. Campbell S, et al. Am J Kidney Dis. 1994 Nov;24(5):819-25. doi: 10.1016/s0272-6386(12)80677-9. Am J Kidney Dis. 1994. PMID: 7977325

5

Non-invasive, optical measurement of absolute blood volume in hemodialysis patients.

Johnson DW, McMahon M, Campbell S, Wilkinson J, Kime N, Shannon G, Fleming SJ. Johnson DW, et al. Kidney Int. 1996 Jan;49(1):255-60. doi: 10.1038/ki.1996.36. Kidney Int. 1996. PMID: 8770977 Free article. No abstract available.

6

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM. Johnson DW, et al. Among authors: campbell sb. Perit Dial Int. 2000 Nov-Dec;20(6):715-21. Perit Dial Int. 2000. PMID: 11216565

7

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients.

Johnson DW, Kay TD, Vesey DA, Isbel N, Campbell SB, Hawley CM. Johnson DW, et al. Among authors: campbell sb. Perit Dial Int. 2000 Nov-Dec;20(6):766-71. Perit Dial Int. 2000. PMID: 11216572

8

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW. Herzig KA, et al. Among authors: campbell sb. J Am Soc Nephrol. 2001 Apr;12(4):814-821. doi: 10.1681/ASN.V124814. J Am Soc Nephrol. 2001. PMID: 11274243

9

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.

Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM. Johnson DW, et al. Among authors: campbell sb. Nephrol Dial Transplant. 2001 Sep;16(9):1879-84. doi: 10.1093/ndt/16.9.1879. Nephrol Dial Transplant. 2001. PMID: 11522873 Clinical Trial.

10

Oral versus intravenous iron supplementation in peritoneal dialysis patients.

Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM. Johnson DW, et al. Among authors: campbell sb. Perit Dial Int. 2001;21 Suppl 3:S231-5. Perit Dial Int. 2001. PMID: 11887827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters